Blackstone Inc’s Cabaletta Bio CABA Stock Holding History

Blackstone Inc’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-46,780	Closed	-$798K	–	180
2024 Q1	$798K	Sell	46,780 -300,714	-87%	-$6.45M	﹤0.01%	146
2023 Q4	$7.89M	Buy	+347,494	New	+$5.84M	0.04%	75
2023 Q3	–	Sell	-498,779	Closed	-$6.44M	–	154
2023 Q2	$6.44M	Sell	498,779 -15,741	-3%	-$171K	0.03%	87
2023 Q1	$4.26M	Sell	514,520 -735,480	-59%	-$6.88M	0.02%	102
2022 Q4	$11.6M	Buy	+1,250,000	New	+$4.55M	0.04%	63

Other funds holding CABA

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Blackstone Inc's CABA Position: Q2 2024 in Review

Blackstone Inc sold out of Cabaletta Bio (CABA) in Q2 2024, closing a stake of 46,780 shares — an estimated $798K sold.

Blackstone Inc first reported a position in CABA in Q4 2022 and held it in 5 quarters. The position peaked at $11.6M in Q4 2022. 142 funds tracked by Wall St. Rank hold CABA as of Q2 2024.

Blackstone Inc reported no remaining Cabaletta Bio position as of Q2 2024 after selling out during the quarter.
Blackstone Inc sold 46,780 Cabaletta Bio shares in Q2 2024, an estimated $798K.
Blackstone Inc first reported a position in Cabaletta Bio in Q4 2022 and held it in 5 quarters.
Blackstone Inc's Cabaletta Bio position peaked at $11.6M in Q4 2022.
142 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2024.

Based on Blackstone Inc's 13F filing for Q2 2024, filed 14 Aug 2024.